Shanghai Junshi Biosciences Co., Ltd. Class ASSE: 688180

"Shanghai Junshi Biosciences Co., Ltd."Announcement on Results of Shareholding Reduction by Shareholder

Aug 20, 2026 · Issued by Shanghai Junshi Biosciences Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Results of Shareholding Reduction by Shareholder

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shanghai Junshi Biosciences Co., Ltd. Class A

"Shanghai Junshi Biosciences Co., Ltd."Indicative Announcement on Change in Equity of Shareholders Holding More Than 5% of the Shares Reaching 1% ThresholdAug 11
"Shanghai Junshi Biosciences Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jul 28
"Shanghai Junshi Biosciences Co., Ltd."Announcement on Results of Issuance of the Second Tranche of Sci-Tech Innovation Bonds in 2026Jul 23
Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLCJul 21

All Shanghai Junshi Biosciences Co., Ltd. Class A news releases